Corresponding author at: Cytogenetics, Department of Clinical Pathology, Hospital Israelita Albert Einstein (HIAE), Av. Albert Einstein, 627, Morumbi, 05652-900 São Paulo, SP, Brazil.
que se leu este artigo
array:24 [ "pii" => "S1516848414000814" "issn" => "15168484" "doi" => "10.1016/j.bjhh.2014.07.008" "estado" => "S300" "fechaPublicacion" => "2014-09-01" "aid" => "45" "copyright" => "Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular" "copyrightAnyo" => "2014" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/3.0/" "subdocumento" => "cor" "cita" => "Rev Bras Hematol Hemoter. 2014;36:379-80" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2173 "formatos" => array:3 [ "EPUB" => 143 "HTML" => 1380 "PDF" => 650 ] ] "itemSiguiente" => array:19 [ "pii" => "S151684841400108X" "issn" => "15168484" "doi" => "10.1016/j.bjhh.2014.08.001" "estado" => "S300" "fechaPublicacion" => "2014-09-01" "aid" => "2371" "copyright" => "Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/3.0/" "subdocumento" => "err" "cita" => "Rev Bras Hematol Hemoter. 2014;36:381" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2303 "formatos" => array:3 [ "EPUB" => 157 "HTML" => 1475 "PDF" => 671 ] ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Erratum</span>" "titulo" => "Erratum to “Are the review criteria for automated complete blood counts of the International Society of Laboratory Hematology suitable for all hematology laboratories?” [Rev. Bras. Hematol. Hemoter. 2014;36(3):219–225]" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "381" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Samuel Ricardo Comar, Mariester Malvezzi, Ricardo Pasquini" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Samuel Ricardo" "apellidos" => "Comar" ] 1 => array:2 [ "nombre" => "Mariester" "apellidos" => "Malvezzi" ] 2 => array:2 [ "nombre" => "Ricardo" "apellidos" => "Pasquini" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S151684841400108X?idApp=UINPBA00005G" "url" => "/15168484/0000003600000005/v1_201409270217/S151684841400108X/v1_201409270217/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S151684841400084X" "issn" => "15168484" "doi" => "10.1016/j.bjhh.2014.07.011" "estado" => "S300" "fechaPublicacion" => "2014-09-01" "aid" => "49" "copyright" => "Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/3.0/" "subdocumento" => "crp" "cita" => "Rev Bras Hematol Hemoter. 2014;36:373-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2798 "formatos" => array:3 [ "EPUB" => 157 "HTML" => 1923 "PDF" => 718 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "Gaucher disease in a family from Maranhão" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "373" "paginaFinal" => "378" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 995 "Ancho" => 1667 "Tamanyo" => 71267 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Family heredogram showing segregation of the two mutations.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Samira Shizuko Parreão Oi, Dario Itapary Nicolau, Sebastião Kelson Alves dos Santos, Marcos Antonio Custódio Neto da Silva, Graça Maria de Castro Viana, Maria do Desterro Soares Brandão Nascimento" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Samira Shizuko Parreão" "apellidos" => "Oi" ] 1 => array:2 [ "nombre" => "Dario Itapary" "apellidos" => "Nicolau" ] 2 => array:2 [ "nombre" => "Sebastião Kelson Alves" "apellidos" => "dos Santos" ] 3 => array:2 [ "nombre" => "Marcos Antonio Custódio Neto" "apellidos" => "da Silva" ] 4 => array:2 [ "nombre" => "Graça Maria" "apellidos" => "de Castro Viana" ] 5 => array:2 [ "nombre" => "Maria" "apellidos" => "do Desterro Soares Brandão Nascimento" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S151684841400084X?idApp=UINPBA00005G" "url" => "/15168484/0000003600000005/v1_201409270217/S151684841400084X/v1_201409270217/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the editor</span>" "titulo" => "Detection of cytogenetic abnormalities in mature B-cell neoplasms: the value of cultures with different mitogens" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "379" "paginaFinal" => "380" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Roberta Maria da Silva Oliveira, Elvira Deolinda Rodrigues Pereira Velloso" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Roberta Maria" "apellidos" => "da Silva Oliveira" "email" => array:1 [ 0 => "roberta_oliveirasp@yahoo.com.br" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Elvira Deolinda Rodrigues Pereira" "apellidos" => "Velloso" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Hospital Israelita Albert Einstein (HIAE), São Paulo, SP, Brazil" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author at</span>: Cytogenetics, Department of Clinical Pathology, Hospital Israelita Albert Einstein (HIAE), Av. Albert Einstein, 627, Morumbi, 05652-900 São Paulo, SP, Brazil." ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Mature B-cell neoplasms are a common group of hematological malignancies in Western counties with the most prevalent being chronic lymphocytic leukemia (CLL). Clonal cytogenetic abnormalities are observed in only 30% of the CLL cases studied by conventional cytogenetic techniques (karyotyping) and up to 80% of the cases studied using the fluorescence in situ hybridization (FISH) technique with probes to investigate 6q21,11q22-23 (ATM), 13q14.3 and 17p13 (P53) deletions and for trisomy 12. Cytogenetic abnormalities are associated with prognosis; deletion of 13q is associated with the best prognosis and deletion of 17p with the worst. Despite the greater sensitivity of FISH, it is expensive and does not detect abnormalities other than those investigated. Conventional cytogenetic studies in CLLs are often disappointing because no metaphases or only normal metaphases are obtained.</p><p id="par0010" class="elsevierStylePara elsevierViewall">It is very important to send a sample containing the neoplastic cells to be analyzed to the lab for the cytogenetic study. In lymphoid malignancies this sample can be from a lymph node, the spleen, or other affected tissue, including bone marrow and peripheral blood when leukemized. The use of mitogenic agents to stimulate B-cells in cultures has been useful. The potent tumor promoter 12-myristate 13-acetate (TPA) has given the highest clone detection rate in the cytogenetic laboratory. Moreover, culturing is performed without any other stimulating agent. In the late 1990s, the use of new cytogenetic protocols with different mitogens such as the CpG-oligonucleotide DSP30 plus interleukin-2 (IL-2) improved the detection of clonal abnormalities in up to 80% in CLL. DSP30 also induces the IL-2 alpha receptor (possibly via CD25) in CLL cells thereby allowing IL-2 to generate a co-stimulatory effect.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The combination of these different mitogens was described by three different groups.</p><p id="par0055" class="elsevierStylePara elsevierViewall">A study by Dicker et al. in Germany, with 132 CLL samples, showed successful cultures in 125 cases, 81% of which showed clonal abnormalities with the most prevalent being del6q, del11q, +12, del13q, del17p and the 14q32 rearrangement.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">In a Brazilian study conducted by Morato et al., clonal cytogenetic abnormalities were detected in 80% of the 35 cases studied, showing recurring abnormalities (del6q, del11q, +12, del13q, −17/del17q, 14q32 rearrangement) as well as many others (+4, +5, +8, +11, +15, del12p13, +18, +19, +21, and balanced translocations involving different chromosomes).<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">A study by Wren et al. in Australia failed to reproduce these data. Forty-five samples of CLL were submitted to cultures stimulated with TPA, DSP30 together with IL-2 and combined TPA and DSP30+IL-2. The rate of detection of chromosomal abnormalities was higher, significance, in the cultures with TPA+DSP30+IL-2 (52.9%) than with TPA (45.8%) or DSP30+IL-2 (29.2%). Additionally, there was a greater success in the culture with TPA (100%) than with DSP30+IL-2 (72.7%) and the mitotic index and resolution of bands were also more successful in the TPA culture.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">In view of these conflicting data in the literature, we compared the detection of clonal abnormalities using three different cultures mentioned in the literature: without stimulating agent, TPA and DSP30+IL-2 (200<span class="elsevierStyleHsp" style=""></span>U/mL) and another with a higher concentration of IL-2 (DSP30+IL-2 [400<span class="elsevierStyleHsp" style=""></span>U/mL]) using 16 samples of mature B-cell neoplasms (11 were CLL). At least ten metaphases from each culture were analyzed in an Ikaros karyotyping System (MetaSystems) by two analysts, and the karyotype was described according to the International System for Human Cytogenetic Nomenclature (ISCN) 2013. <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> shows the results in cases with clonal abnormalities.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">The incidence of clonal abnormalities in mature B-cell neoplasms in this study was 50%, with trisomy 12 being the most common abnormality. The culture with DSP30+IL-2 (400<span class="elsevierStyleHsp" style=""></span>U/mL) showed a lower failure rate than that with DSP30+IL-2 (200<span class="elsevierStyleHsp" style=""></span>U/mL). There was no detection of new clonal abnormalities in the DSP30+IL-2 culture compared to TPA. The culture with the oligonucleotide increased reagent costs of karyotyping by 3% with a lower resolution in G-banding; however, it was able to detect a higher percentage of cells with aberrant clones. Perhaps the combination of the three mitogens may be an effective approach to karyotype mature B-cell neoplasms as suggested by the Australian group.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0045" class="elsevierStylePara elsevierViewall">The authors declare no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2014-03-06" "fechaAceptado" => "2014-06-11" "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">TPA: 12-myristate 13-acetate; oligonucleotide: DSP30; IL-2: interleukin-2.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Cytogenetic abnormalities/neoplasms \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="center" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Culture without stimulant (24 and 48<span class="elsevierStyleHsp" style=""></span>h)(%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="center" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Culture with TPA (72<span class="elsevierStyleHsp" style=""></span>h)(%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="center" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Culture with DSP30 and IL-2 (200<span class="elsevierStyleHsp" style=""></span>U/mL) (72<span class="elsevierStyleHsp" style=""></span>h)(%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="center" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Culture with DSP30 and IL-2 (400<span class="elsevierStyleHsp" style=""></span>U/mL) (72<span class="elsevierStyleHsp" style=""></span>h)(%) \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">−20 (CLL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Absence of metaphases \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Absence of metaphases \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">+12 (CLL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">60.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Absence of metaphases \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">+12, del(14)(q22q24) (B cell neoplasms) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">83.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">85.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Absence of metaphases \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">XXY, der(1)t(1;?)(p13;?), der(3)t(3;?)(p13;?), del(6)(q21)x2, −8, −9, −10, +13, add(19)(p13.3), −22 (B cell neoplasms) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">30.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">80.0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">+12/del(20)(q11.2) (CLL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">50.0/0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">55.5/22.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">80.0/0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">t(1;13)(q?25;q14), add(17)(p12), −18 (CLL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">30.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">60.0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">i(17)(q10) (CLL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">50.0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">+1, del(1)(p34) (B cell neoplasms) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Absence of metaphases \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">40.0 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab563483.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Cytogenetic abnormalities and percentage of abnormal clones in cultures without stimulant, with TPA, DSP30 together with IL-2 (200<span class="elsevierStyleHsp" style=""></span>U/mL) and DSP30 together with IL-2 (400<span class="elsevierStyleHsp" style=""></span>U/mL).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "F. Dicker" 1 => "S. Schnittger" 2 => "T. Haferlach" 3 => "W. Kern" 4 => "C. Schoch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1182/blood-2006-02-005322" "Revista" => array:7 [ "tituloSerie" => "Blood" "fecha" => "2006" "volumen" => "108" "numero" => "9" "paginaInicial" => "3152" "paginaFinal" => "3160" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16840733" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunostimulatory metaphase induction in CLL: correlation with G-banding analysis, spectral karyotyping (SKY), FISH and ZAP70 expression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F.M. Oliveira" 1 => "D.M. Brandão" 2 => "S.D. Leite-Cueva" 3 => "B.P. Simões" 4 => "S.J. Ismael" 5 => "R.P. Falcão" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Bras Hematol Hemoter" "fecha" => "2009" "volumen" => "31" "numero" => "Suppl. 5" "paginaInicial" => "5" "paginaFinal" => "229" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cytogenetic investigations of chronic lymphocytic leukemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C. Wren" 1 => "H. Moriarty" 2 => "K. Marsden" 3 => "E. Tegg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cancergencyto.2009.12.014" "Revista" => array:7 [ "tituloSerie" => "Cancer Genet Cytogenet" "fecha" => "2010" "volumen" => "198" "numero" => "2" "paginaInicial" => "155" "paginaFinal" => "161" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20362231" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15168484/0000003600000005/v1_201409270217/S1516848414000814/v1_201409270217/en/main.assets" "Apartado" => array:4 [ "identificador" => "26323" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15168484/0000003600000005/v1_201409270217/S1516848414000814/v1_201409270217/en/main.pdf?idApp=UINPBA00005G&text.app=http://www.htct.com.br/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1516848414000814?idApp=UINPBA00005G" ]
Ano/Mês | Html | Total | |
---|---|---|---|
2024 Novembro | 0 | 1 | 1 |
2024 Outubro | 33 | 19 | 52 |
2024 Setembro | 30 | 22 | 52 |
2024 Agosto | 33 | 16 | 49 |
2024 Julho | 23 | 15 | 38 |
2024 Junho | 38 | 32 | 70 |
2024 Maio | 43 | 27 | 70 |
2024 Abril | 21 | 18 | 39 |
2024 Março | 43 | 20 | 63 |
2024 Fevereiro | 24 | 25 | 49 |
2024 Janeiro | 30 | 27 | 57 |
2023 Dezembro | 20 | 20 | 40 |
2023 Novembro | 28 | 22 | 50 |
2023 Outubro | 19 | 24 | 43 |
2023 Setembro | 27 | 25 | 52 |
2023 Agosto | 23 | 19 | 42 |
2023 Julho | 27 | 11 | 38 |
2023 Junho | 32 | 19 | 51 |
2023 Maio | 24 | 13 | 37 |
2023 Abril | 17 | 1 | 18 |